345 related articles for article (PubMed ID: 29048949)
1. Discovering Pediatric Asthma Phenotypes on the Basis of Response to Controller Medication Using Machine Learning.
Ross MK; Yoon J; van der Schaar A; van der Schaar M
Ann Am Thorac Soc; 2018 Jan; 15(1):49-58. PubMed ID: 29048949
[TBL] [Abstract][Full Text] [Related]
2. Safety and application of induced sputum analysis in childhood asthma.
Covar RA; Spahn JD; Martin RJ; Silkoff PE; Sundstrom DA; Murphy J; Szefler SJ
J Allergy Clin Immunol; 2004 Sep; 114(3):575-82. PubMed ID: 15356559
[TBL] [Abstract][Full Text] [Related]
3. Relations between exhaled nitric oxide and measures of disease activity among children with mild-to-moderate asthma.
Covar RA; Szefler SJ; Martin RJ; Sundstrom DA; Silkoff PE; Murphy J; Young DA; Spahn JD
J Pediatr; 2003 May; 142(5):469-75. PubMed ID: 12756375
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of budesonide or nedocromil in children with asthma.
; Szefler S; Weiss S; Tonascia J; Adkinson NF; Bender B; Cherniack R; Donithan M; Kelly HW; Reisman J; Shapiro GG; Sternberg AL; Strunk R; Taggart V; Van Natta M; Wise R; Wu M; Zeiger R
N Engl J Med; 2000 Oct; 343(15):1054-63. PubMed ID: 11027739
[TBL] [Abstract][Full Text] [Related]
5. Obese- and allergic-related asthma phenotypes among children across the United States.
Ross MK; Romero T; Sim MS; Szilagyi PG
J Asthma; 2019 May; 56(5):512-521. PubMed ID: 29672178
[TBL] [Abstract][Full Text] [Related]
6. Classification of childhood asthma phenotypes and long-term clinical responses to inhaled anti-inflammatory medications.
Howrylak JA; Fuhlbrigge AL; Strunk RC; Zeiger RS; Weiss ST; Raby BA;
J Allergy Clin Immunol; 2014 May; 133(5):1289-300, 1300.e1-12. PubMed ID: 24892144
[TBL] [Abstract][Full Text] [Related]
7. Effects of budesonide inhalation suspension compared with cromolyn sodium nebulizer solution on health status and caregiver quality of life in childhood asthma.
Murphy KR; Fitzpatrick S; Cruz-Rivera M; Miller CJ; Parasuraman B
Pediatrics; 2003 Sep; 112(3 Pt 1):e212-9. PubMed ID: 12949315
[TBL] [Abstract][Full Text] [Related]
8. Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study.
Silkoff PE; Strambu I; Laviolette M; Singh D; FitzGerald JM; Lam S; Kelsen S; Eich A; Ludwig-Sengpiel A; Hupp GC; Backer V; Porsbjerg C; Girodet PO; Berger P; Leigh R; Kline JN; Dransfield M; Calhoun W; Hussaini A; Khatri S; Chanez P; Susulic VS; Barnathan ES; Curran M; Das AM; Brodmerkel C; Baribaud F; Loza MJ
Respir Res; 2015 Nov; 16():142. PubMed ID: 26576744
[TBL] [Abstract][Full Text] [Related]
9. Repeatability of response to asthma medications.
Wu AC; Tantisira K; Li L; Schuemann B; Weiss S;
J Allergy Clin Immunol; 2009 Feb; 123(2):385-90. PubMed ID: 19064281
[TBL] [Abstract][Full Text] [Related]
10. The Childhood Asthma Management Program (CAMP): design, rationale, and methods. Childhood Asthma Management Program Research Group.
Control Clin Trials; 1999 Feb; 20(1):91-120. PubMed ID: 10027502
[TBL] [Abstract][Full Text] [Related]
11. Early asthma prophylaxis, natural history, skeletal development and economy (EASE): a pilot randomised controlled trial.
Baxter-Jones AD; Helms PJ; Russell G; Grant A; Ross S; Cairns JA; Ritchie L; Taylor R; Reid DM; Osman LM; Robins S; Fletcher ME
Health Technol Assess; 2000; 4(28):1-89. PubMed ID: 11074396
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide interrogation of longitudinal FEV1 in children with asthma.
Wu K; Gamazon ER; Im HK; Geeleher P; White SR; Solway J; Clemmer GL; Weiss ST; Tantisira KG; Cox NJ; Ratain MJ; Huang RS
Am J Respir Crit Care Med; 2014 Sep; 190(6):619-27. PubMed ID: 25221879
[TBL] [Abstract][Full Text] [Related]
13. Forced expiratory volume in 1 second percentage improves the classification of severity among children with asthma.
Fuhlbrigge AL; Weiss ST; Kuntz KM; Paltiel AD;
Pediatrics; 2006 Aug; 118(2):e347-55. PubMed ID: 16864642
[TBL] [Abstract][Full Text] [Related]
14. A randomized, open labeled, comparative study to assess the efficacy and safety of controller medications as add on to inhaled corticosteroid and long-acting β2 agonist in the treatment of moderate-to-severe persistent asthma.
Patel YA; Patel P; Bavadia H; Dave J; Tripathi CB
J Postgrad Med; 2010; 56(4):270-4. PubMed ID: 20935397
[TBL] [Abstract][Full Text] [Related]
15. Budesonide/formoterol maintenance and reliever therapy in moderate-to-severe asthma: effects on eosinophilic airway inflammation.
Takeyama K; Kondo M; Tagaya E; Kirishi S; Ishii M; Ochiai K; Isono K; Tamaoki J
Allergy Asthma Proc; 2014; 35(2):141-7. PubMed ID: 24717791
[TBL] [Abstract][Full Text] [Related]
16. Asthma phenotypes in children and stratified pharmacological treatment regimens.
Iordanidou M; Loukides S; Paraskakis E
Expert Rev Clin Pharmacol; 2017 Mar; 10(3):293-303. PubMed ID: 27936975
[TBL] [Abstract][Full Text] [Related]
17. Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care.
Fajt ML; Wenzel SE
J Allergy Clin Immunol; 2015 Feb; 135(2):299-310; quiz 311. PubMed ID: 25662302
[TBL] [Abstract][Full Text] [Related]
18. Asthma symptoms, morbidity, and antiinflammatory use in inner-city children.
Warman KL; Silver EJ; Stein RE
Pediatrics; 2001 Aug; 108(2):277-82. PubMed ID: 11483788
[TBL] [Abstract][Full Text] [Related]
19. Asthma rescue and allergy medication use among asthmatic children with prior allergy prescriptions who initiated asthma controller therapy.
Luskin A; Bukstein D; Kocevar VS; Yin DD
Ann Allergy Asthma Immunol; 2005 Aug; 95(2):129-36. PubMed ID: 16136761
[TBL] [Abstract][Full Text] [Related]
20. Severe Asthma in Children.
Ramratnam SK; Bacharier LB; Guilbert TW
J Allergy Clin Immunol Pract; 2017; 5(4):889-898. PubMed ID: 28689839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
